Charles River Laboratories International, Inc.

NYSE:CRL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 7.33 B

Share Price

USD 148.93

Avg Daily Volume

989,171

Change (1 day)

0.13%

Change (1 year)

-25.89%

Change (YTD)

-19.32%

Charles River Laboratories International, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 28, 2025: -0.90%

Charles River Laboratories International, Inc. Return on Assets (ROA) is -0.90% for the Trailing 12 Months (TTM) ending June 28, 2025, a -116.67% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Charles River Laboratories International, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 29, 2024 was 5.41%.
Charles River Laboratories International, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 25, 2022 was 6.18%, a -9.35% change year over year.
Charles River Laboratories International, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending June 26, 2021 was 6.82%, a 23.87% change year over year.